Global Anticoagulants Market Size, Share, Growth, Industry Trends and Forecast 2020-2030

Anticoagulants medicine is also known as blood thinners drugs that are prescribed to prevent blood from clotting or stop existing clots from getting larger. The drugs prevent harmful clots forming in the heart, veins or arteries. The formation of clots in the blood can lead to a heart attack or stroke. These drugs are used to treat myocardial infarctions, strokes, pulmonary embolisms, deep vein thrombosis (DVT), and disseminated intravascular coagulation (DIC). The most commonly prescribed anticoagulant is Warfarin and is prescribed to people who are at a higher risk of getting clots. Warfarin and other alternatives are taken as capsules or tablets. Heparin is an anticoagulant that can be given by injection. The most popular types of anticoagulants are novel oral anticoagulants (NOACs), Vitamin K antagonists, and Low-molecular-weight heparin (LMWH). Novel oral anticoagulants (NOACs) have gained immense popularity in recent years due to their multiple benefits. Vitamin K antagonists are prescribed for prolonged anticoagulation therapy. Low-molecular-weight heparin (LMWH) enables outpatient management of disorders, such as pulmonary embolism, deep vein thrombosis, and others. The global anticoagulants market accounted 26837.4 million USD in 2020 and is expected to reach 55312.7 million USD by 2030 with a CAGR of 7.5% approximately during the forecast period.
Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020155
Market Dynamics and Factors:
The growing incidences of cardiovascular disorders, chronic diseases, and venous thromboembolism (VTE), increasing acceptance of novel oral anticoagulants (NOACs), growing awareness regarding the use of NOACs, escalating aging population, lack of precise substitutes for anticoagulant drugs, advantageous government policies, and rising number of obese people are the major factors driving the market. However, the high cost of NOACs, the existence of alternative drugs, stringent government regulations, side-effect risks, and complications related to the use of oral anticoagulants are restricting the growth if global anticoagulants market. Also, increasing investment in R&D in the pharmaceutical sector and the introduction of innovative oral anticoagulant drugs are expected to increase the growth of the market in the future. Stringent regulations implemented by many governments for health safety reasons will be a challenge in the growth of the global anticoagulants market in the short and medium-term.
Market Segmentation :
Global Anticoagulants Market – By Drug Class
Betrixaban
Dabigatran (Pradaxa)
Edoxaban
Rivaroxaban (Xarelto)
Eliquis (Apixaban)
Noacs
Heparin & Lmwh
Vitamin K Antagonist
Others
Global Anticoagulants Market – By Route of Administration
Injectable Anticoagulant
Oral Anticoagulant
Global Anticoagulants Market – By Application
Cardiovascular Diseases
Coronary Artery Diseases
Cardiac Arrhythmia
Myocardial Infarction
DVT
Heart Valve Replacement
Stroke
Atrial Fibrillation
Pulmonary Embolism (PE)
Deep Vein Thrombosis (DVT)
Global Anticoagulants Market – By Geography
North America
U.S.
Canada
Mexico
Europe
U.K.
France
Germany
Italy
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
Rest of Asia Pacific
ROW
Latin America
Middle East
Africa
New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020155
Geographic Analysis:
North America dominates the global anticoagulants market and will lead the global anticoagulants market over the forecast time period, owing to the presence of state-of-the-art healthcare setup, high demand for innovative therapeutics, huge target population, the existence of trained healthcare professionals, and rising incidences of cardiovascular disorders. Europe will be the second-largest market for anticoagulants in the years ahead, due to the escalating aging population, rising occurrences of chronic diseases, advantageous government policies, and the rising number of obese people. The Asia Pacific will grow at a speedy rate over the forecast time period, owing to the huge population, growing number of people suffering from chronic disorders, such as cancer, diabetes, and cardiovascular diseases, promising government policies, and growing investments made by pharmaceutical companies for research and development.
Competitive Scenario:
The major players of the global anticoagulant market are Bayer AG, Aspen Holdings, Boehringer Ingelheim GmbH, Daiichi Sankyo Company, Limited, Bristol-Myers Squibb Company, GlaxoSmithKline, Pfizer, Inc., Sanofi S.A., Johnson & Johnson, and Portola Pharmaceuticals, Inc.
Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020155
How will this Market Intelligence Report Benefit You?
The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.
Exclusive insight into the key trends affecting the Global Anticoagulants industry, although key threats, opportunities and disruptive technologies that could shape the Global Anticoagulants Market supply and demand.
The report tracks the leading market players that will shape and impact the Global Anticoagulants Market most.
The data analysis present in the Global Anticoagulants Market report is based on the combination of both primary and secondary resources.
The report helps you to understand the real effects of key market drivers or retainers on Global Anticoagulants Market business.
The 2021 Annual Global Anticoagulants Market offers:
100+ charts exploring and analysing the Global Anticoagulants Market from critical angles including retail forecasts, consumer demand, production and more
15+ profiles of top producing states, with highlights of market conditions and retail trends
Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand
Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Anticoagulants Market type
Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020155
About Us:
Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.
Contact:
Email: [email protected]
For Latest Update Follow Us:
https://www.facebook.com/Decision-Foresight-110793387201935
https://twitter.com/DecisionFs
https://www.linkedin.com/company/decision-foresight/